- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04926090
Developing Mental Health Supports for Autistic Students
Developing Supports to Address Mental Health Needs of Autistic Students in Postsecondary Education
Study Overview
Status
Conditions
Detailed Description
This study has three specific aims:
Aim 1: Identify mental health needs of autistic students to inform supports. Focus groups engaging key stakeholders will be used to understand the mental health needs of autistic college students and inform adaptation of two individualized mental health supports: 1) the ESP intervention and 2) protocols for monitoring mood and psychological distress.
Aim 2: Develop resources to inform and guide mental health care of autistic students. Focus group information will inform 1) adaptation of clinician (ESP-C) and self-guided (ESP-S) emotional support plans and monitoring protocols and 2) develop a "College Student Mental Health Guide" to aide autistic college students, their families and mental health professionals in proactive planning for mental health supports during PSE.
Aim 3: Assess the feasibility, acceptability and initial efficacy of the ESP-C and ESP-S.
The study will yield preliminary data to apply for additional funding to conduct a large-scale trial to validate these methods to monitor and support mental health of autistic adults. Information gathered from the study will also be used to inform development of a mental health guide for autistic students.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
New Jersey
-
Piscataway, New Jersey, United States, 08854
- Rutgers University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Previous ASD diagnosis,
- Has smartphone (to access the ESP app)
- At least 6th grade Reading Comprehension on the WRAT-5. The WRAT-5 may not be required if a student has other evidence of age-appropriate reading level.
- Be currently enrolled in a Postsecondary Education (PSE) institution.
Exclusion Criteria:
- Not a students in a PSE Institution or do not have diagnosis of ASD
- Score below a 6th grade Reading Comprehension on the WRAT-5
- Unable to understand English
- No access to a compatible iOS and Android smartphone
- the PI's clinical judgment that it would not be in the adult's best interest to be enrolled
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Emotional Support Plan - Clinician Guided (ESP-C) + (Bi)Weekly Monitoring
This will involve brief assessment visits throughout the fall semester, without prompting to use the ESP-C.
Visits will be weekly for the first 6 weeks and then biweekly for the remaining 9 weeks of the term.
|
The Emotional Support Plan (ESP) is designed to help prepare students to cope with stress experienced during postsecondary education.
The ESP-C is delivered by a clinician in 2 sessions.
|
Experimental: Emotional Support Plan - Clinician Guided (ESP-C) + 4x Daily Monitoring
Participants in this arm will be prompted on their phones 4x/day, to report on activities, mood, suicidal ideation, distress level and ESP use since the last prompt.
They will also participate in brief assessment visits conducted weekly for the first 6 weeks and then biweekly for the remaining 9 weeks of the term.
|
The Emotional Support Plan (ESP) is designed to help prepare students to cope with stress experienced during postsecondary education.
The ESP-C is delivered by a clinician in 2 sessions.
|
Experimental: Emotional Support Plan - Self Guided (ESP-S) + 4x Daily Monitoring
Participants in this arm will be prompted on their phones 4x/day, to report on activities, mood, suicidal ideation, distress level and ESP use since the last prompt.
They will be asked to complete questionnaires weekly for the first 6 weeks and then biweekly for the remaining 9 weeks of the term.
|
The Emotional Support Plan (ESP) is designed to help prepare students to cope with stress experienced during postsecondary education.
The ESP-S is created by the participant on their own, with the support of self-guided materials.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in distress on Patient Health Questionnaire (PHQ-9)
Time Frame: 15 week monitoring period
|
The PHQ-9, assessed weekly for first 6 weeks and biweekly for remaining 9 weeks, is a 9-item questionnaire of psychological function over the past week with all items on a "0" (not at all) to "3" (nearly every day) scale.
Higher scores equal more distress.
|
15 week monitoring period
|
Change in distress on Ecological Momentary Assessment (EMA) reports
Time Frame: 15 week monitoring period
|
EMA (Ecological Momentary Assessment) reports of decreased distress (in ESP + daily monitoring groups only).
Scores range from 0(not at all) to 5 (very much).
Higher scores on the item equal higher levels of distress.
|
15 week monitoring period
|
Change in anxiety symptoms on the Generalized Anxiety Disorder Questionnaire (GAD-7)
Time Frame: 15 week monitoring period
|
The GAD-7, assessed weekly, is a 7-item questionnaire of anxiety symptoms over the past week with all items on a "0" (not at all) to "3" (nearly every day) scale.
Higher scores equal more anxiety.
|
15 week monitoring period
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Adult Self Report
Time Frame: 15 week monitoring period
|
The ASR is a measure of adaptive functioning and psychopathology (e.g., anxiety, depression symptoms).
Most of the items are on a 3 point scale including: (0) Not true, (1) Somewhat or sometimes true, and (2) Very often or often true.
Higher scores equal more symptoms.
|
15 week monitoring period
|
Change in Adult Behavior Checklist
Time Frame: 15 week monitoring period
|
The ABCL is a caregiver-report measure of adaptive functioning and psychopathology (e.g., anxiety, depression symptoms).
Most of the items are on a 3 point scale including: (0) Not true, (1) Somewhat or sometimes true, and (2) Very often or often true.
Higher scores equal more symptoms.
|
15 week monitoring period
|
Change in Emotion Dysregulation Inventory
Time Frame: 15 week monitoring period
|
The EDI is a measure of emotion dysregulation designed for use with individuals with autism.
Items are rated on a scale of 0-5.
Higher score equal more symptoms.
|
15 week monitoring period
|
Change Young Adult Coping Orientation for Problem Experience (YA-COPE)
Time Frame: 15 week monitoring period
|
The YA-COPE is a 56-item measure designed to capture coping behaviors of college students.
Items are rated on a scale of 1(never) to 5 (most of the time.
Higher scores indicate more positive strategies.
|
15 week monitoring period
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Vanessa H Bal, PhD, Rutgers University - New Brunswick
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Pro2021000076
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Autism Spectrum Disorder
-
Stanford UniversityCalifornia Department of Developmental ServicesRecruitingAutism Spectrum Disorder | Autistic Disorder | Autism | Autism Spectrum Disorders | Autistic Disorders Spectrum | Autistic Spectrum Disorder | Autistic Spectrum DisordersUnited States
-
Hoffmann-La RocheActive, not recruitingAutism Spectrum Disorder (ASD)United States, Canada, Italy, Spain
-
Axial Therapeutics, Inc.Active, not recruitingAutism Spectrum Disorder (ASD)United States, Australia, New Zealand
-
Technion, Israel Institute of TechnologyCompleted
-
Stanford UniversityNational Institute on Deafness and Other Communication Disorders (NIDCD)CompletedAutism | Autism Spectrum Disorder (ASD)United States
-
Corporacion Parc TauliUnknown
-
Institut de Recherches Internationales ServierADIR, a Servier Group companyTerminatedAutism Spectrum Disorder (ASD)Spain, United States, Hungary, Poland, Australia, United Kingdom, Brazil, Czechia, France, Italy, Portugal, Slovakia
-
Florida Gulf Coast UniversityCompletedAutism Spectrum Disorder High-FunctioningUnited States
-
Hospital Universitario Dr. Jose E. GonzalezUnknownAutism | Autism SpectrumMexico
-
National Taiwan University HospitalCompletedAutism Spectrum Disorder High-FunctioningTaiwan
Clinical Trials on Emotional Support Plan - Clinician Guided (ESP-C)
-
Rutgers, The State University of New JerseyCompletedStress, Psychological | Autism Spectrum Disorder | Psychological DistressUnited States
-
Institut d'Investigació Biomèdica de BellvitgeCompleted